Financhill
Back

Vertex Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

VRTX
Vertex Pharmaceuticals, Inc.

Last Price:
$476.80
Seasonality Move:
4.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Vertex Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Vertex Pharmaceuticals, Inc. has on average historically risen by 25.7% based on the past 34 years of stock performance.
  • Vertex Pharmaceuticals, Inc. has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
  • Is Vertex Pharmaceuticals, Inc. Stock Undervalued?
    The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $476.90. The Score for VRTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Vertex Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Vertex Pharmaceuticals, Inc. has on average historically risen by 25.7% based on the past 34 years of stock performance.

Vertex Pharmaceuticals, Inc. Stock Rating

Buy
55
Vertex Pharmaceuticals, Inc. (VRTX) is a Buy

Is Vertex Pharmaceuticals, Inc. overpriced?

  • Vertex Pharmaceuticals, Inc. has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%

Vertex Pharmaceuticals, Inc. Stock Price History

Is VRTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com

52-Week Data

52-Week High:
519.68
52-Week Low:
362.50

Prediction Charts

Market Cap:
121.1B
Price in USD:
476.90
Volume:
1M
Beta:
0.93

Technical Analysis

SMA50:
461.84
SMA100:
442.09
SMA200:
434.98
52-Wk Change:
-0.71%

Stock Predictions

  • Is Vertex Pharmaceuticals, Inc. stock public?
    Yes, Vertex Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Vertex Pharmaceuticals, Inc. stock quote today?
    The Vertex Pharmaceuticals, Inc. stock price is 476.90 USD today.
  • How to buy Vertex Pharmaceuticals, Inc. stock online?
    You can buy Vertex Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-2 466.79 472.01 473.74 464.01
Feb-3 468.80 465.61 476.83 461.53
Feb-4 470.49 470.52 478.72 467.10
Feb-5 473.90 458.81 478.00 457.74
Feb-6 459.69 477.92 478.28 459.00
Feb-9 476.97 470.87 478.54 467.98
Feb-10 469.83 463.48 474.57 462.24
Feb-11 460.43 461.24 464.73 454.40
Feb-12 462.00 465.02 469.00 460.00
Feb-13 471.65 491.47 503.88 471.65
Feb-17 489.46 477.32 494.05 473.45
Feb-18 473.68 470.31 477.72 466.45
Feb-19 469.83 469.27 472.24 463.00
Feb-20 466.94 476.90 479.12 465.00

Vertex Pharmaceuticals, Inc. Earnings

Vertex Pharmaceuticals, Inc. Earnings Report: Per Share Vertex Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vertex Pharmaceuticals, Inc. Forecast Revenue Growth

Vertex Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.77 per share, and an increase next year of $2.69 per share.

* Vertex Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.